Highlights

  • Oxford-led study explains impact of Covid in Indian subcontinent
  • Combination of AI & new molecular technology used by researchers
  • Independent experts say the findings are very important but require further investigation

Latest news

Omicron variant | Intensive containment, active surveillance, increased vaccination: Centre to states

Omicron variant | Intensive containment, active surveillance, increased vaccination: Centre to states

Oppo Reno7, Reno7 Pro, Reno7 SE launched in China: check specs and price

Oppo Reno7, Reno7 Pro, Reno7 SE launched in China: check specs and price

'I am done! Goodbye! INJUSTICE': comedian Munawar Faruqui hints at quitting comedy

'I am done! Goodbye! INJUSTICE': comedian Munawar Faruqui hints at quitting comedy

Heartbreak for Thailand as ICC cancels Women's World Cup Qualifier

Heartbreak for Thailand as ICC cancels Women's World Cup Qualifier

Pandemic is not over yet, warns PM Modi as new variant raises concerns

Pandemic is not over yet, warns PM Modi as new variant raises concerns

Oxford-led study: gene common in South Asians may double risk of Covid-19 death

The LZTFL1 gene changes the way the lungs respond to viral infection and is the most important genetic risk factor identified so far, the researchers said

Scientists at the University of Oxford have identified a gene that may double the risks of lung failure and death from COVID-19, and could explain why people of South Asian ancestry have a higher risk of severe disease.

The LZTFL1 gene changes the way the lungs respond to viral infection and is the most important genetic risk factor identified so far, the researchers said.

They noted that the gene version is carried by nearly 60 per cent of people with South Asian background, compared with 15 per cent of those with European lineage.

Also watch | Coronavirus: How do Covid-19 boosters work and are they same as the original vaccines?

The finding, published in the journal Nature Genetics on Thursday, could also partly explain the impact of COVID-19 in the Indian subcontinent.

The researchers used a combination of artificial intelligence (AI) and new molecular technology to pinpoint LZTFL1 as a gene responsible for the increased risks.

LZTFL1 blocks a key protective mechanism that cells lining the lungs normally use to defend themselves from the viral infection, they said.

When these cells interact with SARS-CoV-2, which causes COVID-19, one of their defence strategies is to turn into less specialised cells and become less welcoming to the virus.

This process reduces the amount on the surface of cells of a key protein called ACE2, which the coronavirus uses to attach itself to the cells.

However, for people with the LZTFL1 gene this process does not work as well, and lung cells are left vulnerable to infection by the virus.

The researchers noted that it is particularly important to offer vaccination to communities that are at greater risk of serious COVID-19 infection as a consequence of carrying this genetic predisposition, as their increased risk should be cancelled out by immunisation.

Independent experts said the findings are very important but warrant further investigation.

“The discrepancy between the risk of serious disease and death in different ethnic groups has previously been attributed in part to socio-economic differences, but it was clear that this was not a complete explanation," said Professor Frances Flinter, from Guy’s & St Thomas’ NHS Foundation Trust, UK.

“Evidence that LZTFL1 has emerged as a candidate causal gene, which is potentially responsible for some of the two-fold increased risk of respiratory failure from COVID-19 in some populations, provides a big step forward in our understanding of the variable susceptibility of some individuals to serious disease and death,” Flinter, who was not involved in the study, added.

Simon Biddie, from the University of Edinburgh, UK, said the study provides compelling evidence to suggest roles for LZFTL1 in severe COVID-19 that warrants urgent further investigation.

“The finding will need further experimental verification to provide direct evidence for regulation of LZTFL1, using for example genome engineering approaches," Biddie, who was not a part of the study, added.

Up Next

Oxford-led study: gene common in South Asians may double risk of Covid-19 death

Oxford-led study: gene common in South Asians may double risk of Covid-19 death

Omicron variant | Intensive containment, active surveillance, increased vaccination: Centre to states

Omicron variant | Intensive containment, active surveillance, increased vaccination: Centre to states

Experts' description of 'Omicron' variant raises concern

Experts' description of 'Omicron' variant raises concern

Freshers' party in Karnataka turns into 'super-spreader' over 280 infected with Covid

Freshers' party in Karnataka turns into 'super-spreader' over 280 infected with Covid

61 covid cases on South Africa flight, Dutch authorities check for Omicron variant

61 covid cases on South Africa flight, Dutch authorities check for Omicron variant

Variant scare pushes states to issue new rules for travellers, here is what you need to know

Variant scare pushes states to issue new rules for travellers, here is what you need to know

More videos

UK detects first two cases of new the Covid-19 variant
Being punished for detecting new Covid-19 variant, says South Africa
Quarantine on arrival in Mumbai for passengers from South Africa: Mayor
Omicron variant: PM Modi discusses travel curbs as world races to fight new Covid-19 strain
 Merck's pill to treat Covid-19 significantly less effective in new analysis
Why some countries will still have partial curbs as India resumes international flights
'May have greater reinfection risk': WHO says new Covid strain 'variant of concern', names it Omicron
India's tour of South Africa | BCCI to await Centre's decision over new Covid variant
Israel detects first case of new Covid variant, PM warns of 'emergency situation'
Did the new Covid-19 variant evolve in a HIV positive patient?